High diagnostic yields by Sapientia in 100,000 Genomes Project
Congenica's genome analysis platform is detecting clinically relevant variants in 35% of first diagnostic reports delivered to the UK 100,000 Genomes Project.
Consistency and data sharing vital to unlock value of genetic testing
“At Congenica we realise that there is huge value in being able to share data to see how others have interpreted the same gene variant,” says Dr Matthew Hurles, co-founder of Congenica, a world leader in genomic analysis and interpretation. He will explain how the bottlenecks of consistency and data sharing are being addressed in a presentation at Congenica’s Education Event, at the annual…
OBN awards Congenica 'Best implementation of digital healthcare’
Congenica was given the accolade of ‘Best Implementation of Digital Healthcare’ in the OBN awards. Congenica has introduced its Sapientia platform into the NHS - one of the most highly regulated healthcare systems in the world - in just two years.
Companies need 'someone with a vision and the right team to make it work'
Dr Tom Weaver, CEO of Congenica, shares the secrets of success at the Innovation Forum 2016 - Leaders Conference in Cambridge tomorrow (21 September).
Is the virtual gene panel the way forward, asks Congenica at Dx Summit
Mike Furness of Cambridge-based genomics analysis company Congenica says more clinical input is required to ensure consistency.
Personalised medicine: dose by design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs. In the recent BBC Radio 4 programme Personalised Medicine: Dose by Design, a panel of experts, including Nick Lench, Congenica’s Chief Operating Officer, discussed with Vivienne Parry what the arrival of this new methodology entails for the NHS.
New karyogram display improves Sapientia for clinical diagnosis
Workflow and data visualisation features for Congenica's interpretation platform support whole exome sequencing.
Creativity, roadmapping, devising technology strategies: key R&D issues
Launch of R&D Today community website aims to be the ‘trip advisor’ of best practice.
Congenica’s Sapientia selected for ‘PAGE’ prenatal genetic testing project
Congenica announces at the ‘Curating the Clinical Genome’ conference,that its genomic interpretation technology is to be used for the first time in a prenatal testing project.
Cambridge 'brain gain' as inward investment grows
When Amazon acquired Cambridge-based Evi Technologies it also decided to invest in the city; building a large development centre to house the Evi Team and others such as Prime Air, in order to benefit from the entrepreneurial landscape. This is an example of a growing trend of multi-national companies attracted to the city, identified by the new book Cambridge Phenomenon: Global Impact.
Location, location: the secret Cambridge success story
The influence of Cambridge as a powerhouse for innovation has been underestimated, according to the new book The Cambridge Phenomenon: Global Impact, launched at the University of Cambridge.
Congenica takes Birmingham Women's Hospital to the forefront of genomic diagnosis
Birmingham Women's Hospital adopts Congenica’s Sapientia for gene-disease insights that reclassify disease.
Tri-Con 2016 marks new era of genomic medicine, says Congenica
Mike Furness of Congenica says that Molecular Medicine Tri-Con 2016 comes at an exciting time for the industry.
Rare disease or rare success: a tale of two genomes
Congenica is to help a woman who self-diagnosed the genetic cause of both her muscle-wasting disease and an Olympic athlete’s extreme muscular physique.
Rare Disease Day focuses on new approach to finding treatment
Findacure says it could save the NHS millions of pounds, based on US experience.
Congenica achieves ISO 27001 and NHS IGT accreditation
Congenica, a world leading developer of genome analysis technologies, places the highest importance on data security and information governance and is therefore pleased to announce that it has successfully achieved two major milestones: ISO 27001 accreditation and compliance with the NHS Information Governance Toolkit (IGT).
UCB works with Congenica to support rare disease genomic research
As a leader in genomic interpretation, Congenica is excited to begin working with UCB, enabling researchers to bridge genomics and drug development and bring much needed treatments to patients.
To get ahead, women bio-entrepreneurs do it for themselves
The 50 Movers and Shakers report is launched ahead of the BioBeat conference later this week.
Rethinking bio-innovation: BioBeat15
New models and strategies for business will be discussed by an all-women panel at the forthcoming BioBeat15 conference on Friday 20th November. Open to all, the event brings together stakeholders in genomics, pharma, biotech and beyond to share ideas and meet like-minded individuals.
Congenica and GenomOncology announce collaborative agreement
Congenica, leader in genomic interpretation and diagnostics in rare genetic disease, and GenomOncology, specialists in precision medicine technology in the field of oncology, are announcing a pilot collaboration that will support the commercialisation of each other’s products in the USA and UK respectively and offer strategic partners a scalable data platform.
Guilt, shame and pressure: the emotional toll of infertility
The emotional and psychological impact of infertility is being highlighted by fertility counsellors who support patients at Bourn Hall Clinic, to increase understanding of this medical condition during ‘Fertility Awareness Week’ next week (2-8 November).
Accelerators take us 'Back to the Future' to discover new materials
The world is gearing up for the biggest physics experiment ever and it will take us ‘back to the future’ according to Professor Carsten P Welsch of the Cockcroft Institute, Communications Coordinator for the European Circular Energy-Frontier Collider (EuroCirCol) project, which is designing a successor to the Large Hadron Collider (LHC).
Unique collaboration between NHSA and Congenica announced at BIA Bioscience Forum
Rare disease diagnosis will be available in days, not years, as a new agreement paves the way for a consistent diagnostic platform across the North of England.
Genomics England announces Congenica as an interpretation partner
Genomics England announces that Congenica has won a contract to provide genome interpretation for 8000 patients participating in the 100,000 Genomes Project.
Congenica awarded £300k Innovate UK grant to unlock stratified medicine
Life Sciences Minister George Freeman MP today announced at the GREAT Healthcare Week at the Milan Expo, that Congenica, a world leading developer of genome-based discovery and diagnostic technologies, has been awarded £300,000 by Innovate UK as part of its ‘Finding value in complex data’ competition.